Click here to view online. Add this email to your safelist.

AstraZeneca logo

Hidden in Plain Sight: The True Burden of Obesity & Diabetes

5 November 2025

Real-world findings from the CALOR study programme reveal widespread underdiagnosis and late recognition of obesity, highlighting missed opportunities for early intervention. Explore how science and data can drive earlier, integrated action to reduce global cardiometabolic and renal disease burden.

Read more  Read more

RSS Feed  RSS Feed Twitter  Follow us on Twitter LinkedIn  Follow us on LinkedIn
Legal notice and Terms of Use Privacy policy Cookie policy Site map © AstraZeneca 2022

For more information please visit astrazeneca.com.

If you would like to unsubscribe please click here.